Primovist / Eovist in Renally Impaired Patients (Q64675538)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Primovist / Eovist in Renally Impaired Patients |
clinical trial |
Statements
PERI (English)
0 references
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information. (English)
0 references
May 2009
0 references
July 2013
0 references
357
0 references
18 year
0 references